Daily SPAC Update – August 5, 2025

by | Aug 5, 2025

Helix Acquisition + BridgeBio Oncology Deal Approved. Southport Acquisition + Angel Studios Deal Vote Set.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
HLXB – HELIX ACQUISITION CORP II * Deal Approved with BridgeBio Oncology Therapeutics

SPAC DEAL & EXTENSION VOTES SET
PORT – Southport Acquisition Corp * DEAL VOTE SET: Aug 22, 2025 * trust $11.54

OTHER SPAC NEWS
CSLMF – CSLM ACQUISITION CORP * Forward Purchase Agreement
PLMJF – PLUM ACQUISITION CORP III * Merger Agreement Amendment
CCCM – COLUMBUS CIRCLE CAPITAL CORP I * Media Transcript

SEPARATE WARRANTS/RIGHTS
Aug 04: BLUE ACQUISITION CORP (BACC)

NEW SPAC IPOs
Aug 01: HCMA – HCM III Acquisition Corp. $220M IPO (+underwriter overallotment: $33M)
Jul 30: APAD – A Paradise Acquisition Corp. $200M IPO

SPAC Movers

YESTERDAY’S TOP SPAC GAINERS
27.41% ~ $ 13.11 | FACT – FACT II ACQUISITION CORP (Pre-Deal)
7.92% ~ $ 28.60 | CEP – CANTOR EQUITY PARTNERS INC (Announced)
4.55% ~ $ 11.02 | YORK – YORKVILLE ACQUISITION CORP (Pre-Deal)
3.04% ~ $ 11.88 | RTAC – RENATUS TACTICAL ACQUISITION CORP I (Pre-Deal)
2.11% ~ $ 11.13 | CEPO – CANTOR EQUITY PARTNERS I INC (Announced)

YESTERDAY’S TOP SPAC LOSERS
-8.95% ~ $ 9.50 | HLXB – HELIX ACQUISITION CORP II (Announced)
-2.96% ~ $ 9.82 | CHEB – CHENGHE ACQUISITION II CO (Announced)
-2.03% ~ $ 10.64 | DYNX – DYNAMIX CORP (Announced)
-1.15% ~ $ 11.17 | AFJK – AIMEI HEALTH TECHNOLOGY CO LTD (Announced)
-1.05% ~ $ 10.30 | GTEN – GORES HOLDINGS X INC (Pre-Deal)

LATEST SPAC IPO PERFORMANCE
Aug 01 | HCMA – HCM III Acquisition Corp.
Jul 30 | APAD – A Paradise Acquisition Corp.
Jul 17 | $ 10.03 | PAII – Pyrophyte Acquisition Corp. II
Jul 16 | $ 10.05 | SOCA – Solarius Capital Acquisition Corp.
Jul 15 | $ 10.15 | SPEG – Silver Pegasus Acquisition Corp.
Jul 09 | $ 10.20 | GTER – Globa Terra Acquisition Corporation

 

 

Recent Analysis

Daily SPAC Update – August 6, 2025

FG Merger II Taking Boxabl Public in $6.3 Billion Deal. Presidio Petroleum in $664 Million Deal with EQV Ventures. Flagship Sets Date to Vote on Extension Fee Changes. ByNordic Extension Vote.

Daily SPAC Update – August 4, 2025

CSLM + Fusemachines Deal Approved (plus FPA). Helix Aquisition II + Bridge Bio Oncology Therapeutics Deal Vote. Blue Acquisition Separate Trading.

Executive Moves Update – August 1, 2025

CEO and CFO transitions at Dexcom, Carlyle, Roku, Warner Bros. Discovery, MetLife, and Five9. New board members at Chevron, BioMarin, Celestica, Elevance Health, GXO Logistics, and more. Executive leadership changes and governance red flags across U.S. public companies for the week of July 28 – August 1, 2025.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.